With Mariah Ultramari, PhD, Toxicologist and CEO of Spektra Consulting
What you will learn:
- Historic content focus on the acceptable limit definition for Nitrosamines
- Challenges to set NDSRI acceptable intakes
- New approaches to set AI (Acceptable Intake) – CPCA (EMA and FDA)
- Next steps